Inhibitory effects of S-allylmercaptocysteine against benzo(a)pyrene-induced precancerous carcinogenesis in human lung cells
Copyright © 2016 Elsevier B.V. All rights reserved..
The anti-cancer effects of oil-soluble organosulfur compounds in garlic in the initiation phase of carcinogenesis are known. However, there are few experimental studies investigating S-allylmercaptocysteine (SAMC), a water-soluble derivative of garlic. This study investigated whether SAMC prevented the carcinogen benzo(a)pyrene (B(a)P) from inducing precancerous activity in human lung cells (A549 cell line). A549 cells were either pre-treated (PreTM) or concurrently treated (CoTM) with 1μM B(a)P and either 10 or 50 μM SAMC. The 50 μM PreTM group inhibited B(a)P-induced cell proliferation by approximately 100%. The 50 μM SAMC PreTM and CoTM inhibited the B(a)P-induced G2/M phase shift by 100% and 97%, respectively. Furthermore, the PreTM and CoTM groups exhibited the potential to reduce the generation of reactive oxygen species (ROS) relative to the B(a)P group by at least 78%. The SAMC PreTM elevated superoxide dismutase (SOD) by approximately 100%. In this study, we revealed the mechanisms involved in SAMC inhibition of B(a)P-induced carcinogenesis, including suppression of cell proliferation, cell cycle regulation, attenuation of ROS formation, inhibition of DNA damage, increase of SOD activity and inhibition of nuclear factor-kappa B (NF-κB) activity. SAMC appears to be a novel therapeutic candidate for the prevention and treatment of B(a)P-induced human lung cancer.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2016 |
---|---|
Erschienen: |
2016 |
Enthalten in: |
Zur Gesamtaufnahme - volume:34 |
---|---|
Enthalten in: |
International immunopharmacology - 34(2016) vom: 26. Mai, Seite 37-43 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Wang, Kaiming [VerfasserIn] |
---|
Links: |
---|
Anmerkungen: |
Date Completed 30.12.2016 Date Revised 11.03.2022 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1016/j.intimp.2016.02.017 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM257882057 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM257882057 | ||
003 | DE-627 | ||
005 | 20231224183804.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231224s2016 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.intimp.2016.02.017 |2 doi | |
028 | 5 | 2 | |a pubmed24n0859.xml |
035 | |a (DE-627)NLM257882057 | ||
035 | |a (NLM)26919281 | ||
035 | |a (PII)S1567-5769(16)30052-2 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Wang, Kaiming |e verfasserin |4 aut | |
245 | 1 | 0 | |a Inhibitory effects of S-allylmercaptocysteine against benzo(a)pyrene-induced precancerous carcinogenesis in human lung cells |
264 | 1 | |c 2016 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 30.12.2016 | ||
500 | |a Date Revised 11.03.2022 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Copyright © 2016 Elsevier B.V. All rights reserved. | ||
520 | |a The anti-cancer effects of oil-soluble organosulfur compounds in garlic in the initiation phase of carcinogenesis are known. However, there are few experimental studies investigating S-allylmercaptocysteine (SAMC), a water-soluble derivative of garlic. This study investigated whether SAMC prevented the carcinogen benzo(a)pyrene (B(a)P) from inducing precancerous activity in human lung cells (A549 cell line). A549 cells were either pre-treated (PreTM) or concurrently treated (CoTM) with 1μM B(a)P and either 10 or 50 μM SAMC. The 50 μM PreTM group inhibited B(a)P-induced cell proliferation by approximately 100%. The 50 μM SAMC PreTM and CoTM inhibited the B(a)P-induced G2/M phase shift by 100% and 97%, respectively. Furthermore, the PreTM and CoTM groups exhibited the potential to reduce the generation of reactive oxygen species (ROS) relative to the B(a)P group by at least 78%. The SAMC PreTM elevated superoxide dismutase (SOD) by approximately 100%. In this study, we revealed the mechanisms involved in SAMC inhibition of B(a)P-induced carcinogenesis, including suppression of cell proliferation, cell cycle regulation, attenuation of ROS formation, inhibition of DNA damage, increase of SOD activity and inhibition of nuclear factor-kappa B (NF-κB) activity. SAMC appears to be a novel therapeutic candidate for the prevention and treatment of B(a)P-induced human lung cancer | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Research Support, Non-U.S. Gov't | |
650 | 4 | |a A549 | |
650 | 4 | |a Benzo(a)pyrene | |
650 | 4 | |a Cancer therapy | |
650 | 4 | |a NF-κB | |
650 | 4 | |a ROS | |
650 | 4 | |a S-allylmercaptocysteine | |
650 | 7 | |a NF-kappa B |2 NLM | |
650 | 7 | |a Reactive Oxygen Species |2 NLM | |
650 | 7 | |a S-allylmercaptocysteine |2 NLM | |
650 | 7 | |a Benzo(a)pyrene |2 NLM | |
650 | 7 | |a 3417WMA06D |2 NLM | |
650 | 7 | |a Superoxide Dismutase |2 NLM | |
650 | 7 | |a EC 1.15.1.1 |2 NLM | |
650 | 7 | |a Cysteine |2 NLM | |
650 | 7 | |a K848JZ4886 |2 NLM | |
700 | 1 | |a Wang, Ying |e verfasserin |4 aut | |
700 | 1 | |a Qi, Qiuchen |e verfasserin |4 aut | |
700 | 1 | |a Zhang, Fang |e verfasserin |4 aut | |
700 | 1 | |a Zhang, Yongchun |e verfasserin |4 aut | |
700 | 1 | |a Zhu, Xiaosong |e verfasserin |4 aut | |
700 | 1 | |a Liu, Guangpu |e verfasserin |4 aut | |
700 | 1 | |a Luan, Yuxia |e verfasserin |4 aut | |
700 | 1 | |a Zhao, Zhongxi |e verfasserin |4 aut | |
700 | 1 | |a Cai, Jianhua |e verfasserin |4 aut | |
700 | 1 | |a Cao, Jimin |e verfasserin |4 aut | |
700 | 1 | |a Li, Shanzhong |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t International immunopharmacology |d 2001 |g 34(2016) vom: 26. Mai, Seite 37-43 |w (DE-627)NLM112639542 |x 1878-1705 |7 nnns |
773 | 1 | 8 | |g volume:34 |g year:2016 |g day:26 |g month:05 |g pages:37-43 |
856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.intimp.2016.02.017 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 34 |j 2016 |b 26 |c 05 |h 37-43 |